Thierry Durroux Selected Research

Chemokine Receptors

1/2020	The atypical chemokine receptor 3 interacts with Connexin 43 inhibiting astrocytic gap junctional intercellular communication.
12/2019	Context-Dependent Signaling of CXC Chemokine Receptor 4 and Atypical Chemokine Receptor 3.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Thierry Durroux Research Topics

Disease

2	Neoplasms (Cancer) 01/2020 - 12/2019
2	Infections 12/2019 - 01/2017
2	Autistic Disorder (Autism) 10/2018 - 01/2018
2	Hyponatremia 09/2010 - 01/2008
1	Mental Disorders (Mental Disorder) 05/2023
1	Glioblastoma (Glioblastoma Multiforme) 01/2020
1	Autism Spectrum Disorder 10/2018
1	Pain (Aches) 01/2018
1	Parkinson Disease (Parkinson's Disease) 01/2018
1	Human Influenza (Influenza) 01/2017
1	Parkinsonian Disorders (Parkinsonism) 01/2015
1	Nephrogenic Syndrome of Inappropriate Antidiuresis 09/2010
1	Nephrogenic Diabetes Insipidus 10/2009
1	Premature Obstetric Labor (Premature Labor) 10/2005

Drug/Important Bio-Agent (IBA)

2	Chemokine ReceptorsIBA 01/2020 - 12/2019
2	Oxytocin (Pitocin)FDA LinkGeneric 10/2018 - 10/2005
2	Vasopressin Receptors (Arginine Vasopressin Receptor)IBA 09/2010 - 10/2009
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 05/2023
1	Connexin 43 (Connexin43)IBA 01/2020
1	CXCR ReceptorsIBA 12/2019
1	LIT-001IBA 10/2018
1	Oxytocin Receptors (Oxytocin Receptor)IBA 10/2018
1	Glutamic Acid (Glutamate)FDA Link 01/2018
1	Histamine (Histamine Dihydrochloride)FDA Link 01/2017
1	Interferon Type IIBA 01/2017
1	Dopamine (Intropin)FDA LinkGeneric 01/2015
1	Purinergic P1 Receptors (Adenosine Receptor)IBA 01/2015
1	Vasopressins (Vasopressin)IBA 09/2010
1	Aquaporin 2IBA 09/2010
1	Arginine Vasopressin (Argipressin)IBA 10/2009
1	satavaptanIBA 01/2008
1	lixivaptanIBA 01/2008
1	conivaptan (Vaprisol)FDA Link 01/2008
1	Tolvaptan FDA Link 01/2008
1	peptide VIBA 01/2008
1	Tocolytic Agents (Tocolytics)IBA 10/2005
1	atosibanIBA 10/2005
1	Peptides (Polypeptides)IBA 10/2005